
    
      A consecutive case series of patients with angioid streaks that developed subfoveal choroidal
      neovascularization were treated with a primary 2.5 mg injection of Bevacizumab (Avastin)
      intravitreally. All patients were evaluated with BCVA at 1, 2 , 4 and 12 weeks and OCT and
      fluoresceine angiography at month 1 and 3. (Patients will be follow 6 months)
    
  